Mednet Logo
HomeQuestion

What is the preferred agent for metastatic male breast cancer patient who progresses on tamoxifen and is not a candidate for chemotherapy?

1
2 Answers
Mednet Member
Mednet Member
Medical Oncology · Private Practice and Digital Health

This is luckily not a common scenario. Metastatic breast cancer in men is quite unusual in a typical practice, primarily because the disease is rare to begin with and we would most often see men with non-metastatic disease.

Of course, the majority of breast cancers in men are ER-positive, more than w...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Duke University
For endocrine therapies for metastatic breast cancer in men, after initial response to tamoxifen and then progression, as in premenopausal women, treatment should include suppression of gonadal function. When there is no response to first-line endocrine therapy with tamoxifen, the chance of response...

Register or Sign In to see full answer